| DNA Next Generation Sequencing Market Analysis and Research Report by Experts 2025 |
The DNA next generation sequencing market growth is attributed owing to increasing number of cancer cases across the globe, rising research studies, increasing collaborations between research institutes and market players along with rising applications of DNA next generation sequencing and technological advancements in sequencing technologies. However, the dearth of skilled professionals is expected to critically impact the overall DNA next generation sequencing market growth.
Next generation sequencing is also known as high-throughput sequencing. NGS enables rapid sequencing of the base pairs in DNA samples. NGS is driving the drug discovery application and enabling the future of personalized medicine, genetic diseases, and clinical diagnostics. Moreover, next-generation sequencing (NGS) is a massively parallel sequencing technology that can establish the order of nucleotides in a whole genome with scalability, ultra-high throughput, and fast speed. Since it includes preparing the sample for the subsequent sequencing reaction, DNA pre-sequencing is one of the most important processes in the total sequencing protocol. In the global healthcare sector, NGS is steadily being integrated into clinical laboratory analysis, testing, and disease diagnoses. In pharmacogenomics, NGS has been widely employed to speed up the drug discovery process.
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis – https://www.theinsightpartners.com/sample/TIPRE00002934/
Leading companies in the market:
- Illumina, Inc.
2. Thermo Fisher
3. Qiagen N.V.
4. Beijing Genomics Institute
5. PerkinElmer, Inc.
6. Hoffman-La Roche Ltd.
7. Agilent Technologies
8. Eurofins Scientific
9. Oxford Nanopore Technologies Ltd.
10. Macrogen Inc.
DNA Next Generation Sequencing Market: Segmental Overview
Product-Based Insights
The global market, based on product, is segmented into platforms, services, and consumables. The platform segment is further sub-segmented into HiSeq Series, MiSeq Series, SOLiD, Ion Torrent, Pacbio Rs II and Sequel Systems, and others. Further, the services segment is sub-segmented into sequencing services and data management and analysis services. The consumables segment is also sub-segmented into sample preparation consumables and other NGS consumables. The consumables segment held a larger share among the product subsegments in 2017 and is also anticipated to follow a similar trend over the forecast period. Consumables depend on various requirements to be performed in the preparation of the genome library. The robotic systems require larger amounts, in turn, increases the cost of the sample. The consumables are used in the numerous stages of the next-generation sequencing procedures, including sample generation, storing the samples and their purification, preparation of the library and quantification, and PCR amplification.
Application-Based Insights
The global market, based on application, is segmented into diagnostics, drug discovery, precision medicine, and other applications. The diagnostics segment held the largest share in 2017 and is expected to witness significant growth over the next five to six years. Clinical laboratories have increasingly adopted next-generation sequencing (NGS) as a standard for diagnosing hereditary disorders. Depending upon the specific focus of the diagnostic laboratory, NGS methods can be used to detect either germline or somatic mutations.
End User-Based Insights
The global market, based on end user, is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & clinics, and other end users. NGS can also be used to predict the response to or adverse effects of drugs or to calculate appropriate drug dosage. This led hospitals and clinics to use this technology significantly, which would generate better outcomes and be more patient-centric.
Our reports will help clients solve the following issues: –
Insecurity about the future:
Our research and insights help our clients anticipate upcoming revenue compartments and growth ranges. This will help our clients invest or divest their assets.
Understanding market opinions:
It is extremely vital to have an impartial understanding of market opinions for a strategy. Our insights provide a keen view on the market sentiment. We keep this reconnaissance by engaging with Key Opinion Leaders of a value chain of each industry we track.
Understanding the most reliable investment centers:
Our research ranks investment centers of market by considering their future demands, returns, and profit margins. Our clients can focus on most prominent investment centers by procuring our market research.
Evaluating potential business partners:
Our research and insights help our clients identify compatible business partners.
Immediate delivery of our off-the-shelf reports and pre booking of upcoming studies, through flexible and convenient payment methods – https://www.theinsightpartners.com/buy/TIPRE00002934/
In-Vitro Diagnostics Market Segmented by Region/Country: North America, Europe, Asia Pacific, Middle East & Africa, and Central & South America
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
HealthcareTrends 